Influence of genetic variations in IL1B on brain region volumes in bipolar patients and controls
暂无分享,去创建一个
M. Landén | B. Liberg | E. Pålsson | A. Ekman | Nina Strenn
[1] Sarah L Bergen,et al. Longitudinal Cortical Thickness Changes in Bipolar Disorder and the Relationship to Genetic Risk, Mania, and Lithium Use , 2020, Biological Psychiatry.
[2] J. Hsu,et al. Inflammation associated with volume reduction in the gray matter and hippocampus of older patients with bipolar disorder. , 2019, Journal of affective disorders.
[3] C. Pantelis,et al. An Interleukin-1 beta (IL1B) haplotype linked with psychosis transition is associated with IL1B gene expression and brain structure , 2019, Schizophrenia Research.
[4] K. Simonyan. Recent advances in understanding the role of the basal ganglia , 2019, F1000Research.
[5] Haihua Qian,et al. Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study , 2018, Aging.
[6] P. Petrovic,et al. Bipolar disorder type I and II show distinct relationships between cortical thickness and executive function , 2018, Acta psychiatrica Scandinavica.
[7] M. Maes,et al. The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder , 2018, Molecular Neurobiology.
[8] C. Hultman,et al. Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls , 2017, Psychiatry Research.
[9] A. Carvalho,et al. Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies , 2017, The international journal of neuropsychopharmacology.
[10] Erick Jorge Canales-Rodríguez,et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group , 2017, Molecular Psychiatry.
[11] M. Corredor,et al. A Review of Polymorphisms in Genes Involved in the Development of Gastric Cancer , 2016 .
[12] E. Olsson,et al. Cognitive reserve lessens the burden of white matter lesions on executive functions in bipolar disorder , 2016, Psychological Medicine.
[13] P. Petrovic,et al. Cortical thickness, volume and surface area in patients with bipolar disorder types I and II. , 2016, Journal of psychiatry & neuroscience : JPN.
[14] Amit Anand,et al. Differential Resting-State Functional Connectivity of Striatal Subregions in Bipolar Depression and Hypomania , 2016, Brain Connect..
[15] Xiaoping P. Hu,et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression , 2015, Molecular Psychiatry.
[16] K. Blennow,et al. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment , 2015, European Neuropsychopharmacology.
[17] D. Woods,et al. Hemispheric asymmetries in cortical and subcortical anatomy , 2015, Laterality.
[18] S. Hansen,et al. Cognitive Functioning in Clinically Stable Patients with Bipolar Disorder I and II , 2015, PloS one.
[19] M. Pawlak,et al. Basal Ganglia Volumes: MR-Derived Reference Ranges and Lateralization Indices for Children and Young Adults , 2014, The neuroradiology journal.
[20] C. Ekman,et al. Vertex-based morphometry in euthymic bipolar disorder implicates striatal regions involved in psychomotor function , 2014, Psychiatry Research: Neuroimaging.
[21] C. Davis,et al. Obesity Elicits Interleukin 1-Mediated Deficits in Hippocampal Synaptic Plasticity , 2014, The Journal of Neuroscience.
[22] T. Robbins,et al. Neuroscience and Biobehavioral Reviews Review from the Ventral to the Dorsal Striatum: Devolving Views of Their Roles in Drug Addiction , 2022 .
[23] D. Walker,et al. Cytokines and the neurodevelopmental basis of mental illness , 2013, Front. Neurosci..
[24] Teresa A. Victor,et al. Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities , 2013, Brain, Behavior, and Immunity.
[25] E. Brietzke,et al. Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies , 2013, Biological Psychiatry.
[26] P. Calabresi,et al. Effects of central and peripheral inflammation on hippocampal synaptic plasticity , 2013, Neurobiology of Disease.
[27] B. Czéh,et al. Antidepressants act directly on astrocytes: Evidences and functional consequences , 2013, European Neuropsychopharmacology.
[28] R. Nitsch,et al. Absence of IL-1β positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury , 2013, Journal of Neuroinflammation.
[29] C. Ekman,et al. Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls , 2012, BMC Psychiatry.
[30] L. Fañanás,et al. Effect of the Interleukin-1β Gene on Dorsolateral Prefrontal Cortex Function in Schizophrenia: A Genetic Neuroimaging Study , 2012, Biological Psychiatry.
[31] T. Suslow,et al. Tumor Necrosis Factor Gene Variation Predicts Hippocampus Volume in Healthy Individuals , 2012, Biological Psychiatry.
[32] Walter Heindel,et al. Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain , 2012, Journal of Neuroinflammation.
[33] J. Kowalski,et al. Interleukin-1beta Promoter (−31T/C and −511C/T) Polymorphisms in Major Recurrent Depression , 2011, Journal of Molecular Neuroscience.
[34] Jin Fan,et al. Common and distinct networks underlying reward valence and processing stages: A meta-analysis of functional neuroimaging studies , 2011, Neuroscience & Biobehavioral Reviews.
[35] M. Landén,et al. Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder. , 2011, Journal of psychiatry & neuroscience : JPN.
[36] J. Ordovás,et al. Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolism. , 2011, The Journal of clinical endocrinology and metabolism.
[37] M. Berk,et al. eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors , 2010 .
[38] M. Ingvar,et al. Manic episodes are associated with grey matter volume reduction — a voxel‐based morphometry brain analysis , 2010, Acta psychiatrica Scandinavica.
[39] Lin He,et al. Convergent Evidence Shows a Positive Association of Interleukin-1 Gene Complex Locus with Susceptibility to Schizophrenia in the Caucasian population , 2010, Schizophrenia Research.
[40] L. Boulanger,et al. Immune Proteins in Brain Development and Synaptic Plasticity , 2009, Neuron.
[41] S. Tsai,et al. Interleukin-1 Beta −511C/T Genetic Polymorphism is Associated with Age of Onset of Geriatric Depression , 2009, NeuroMolecular Medicine.
[42] R. McIntyre,et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. , 2009, The Journal of clinical psychiatry.
[43] L. Fañanás,et al. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin‐1 beta gene (2q13) , 2008, Genes, brain, and behavior.
[44] A. Galor,et al. Transient band keratopathy associated with ocular inflammation and systemic hypercalcemia , 2008, Clinical ophthalmology.
[45] Matthias J. Müller,et al. Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression , 2008, Neuropsychiatric disease and treatment.
[46] N. Rothwell,et al. Interleukin-1 and inflammatory neurodegeneration. , 2007, Biochemical Society transactions.
[47] C. Cannings,et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. , 2006, Human molecular genetics.
[48] P. Renshaw,et al. Basal ganglia shape alterations in bipolar disorder. , 2006, The American journal of psychiatry.
[49] Olga V. Demler,et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.
[50] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[51] B. Gutiérrez,et al. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder , 2004, Journal of Medical Genetics.
[52] S. Tsai,et al. Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response , 2003, Neuropsychopharmacology.
[53] U Hegerl,et al. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. , 2001, The American journal of psychiatry.
[54] M. Carrington,et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.
[55] N. Herrmann,et al. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis. , 2018, Journal of affective disorders.
[56] D. Steffens,et al. Putamen Volume Differences Among Older Adults: Depression Status, Melancholia, and Age , 2018, Journal of geriatric psychiatry and neurology.
[57] J. Price,et al. Neurocircuitry of Mood Disorders , 2010, Neuropsychopharmacology.
[58] Patricia A. Berglund,et al. Lifetime prevalence and age of onset distributions of mental disorders in the World Mental Health Survey Initiative. , 2008 .